- GYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13D Filing
Gyre Therapeutics (GYRE) SC 13DCatalyst Biosciences, Inc.
Filed: 23 Jul 19, 9:00am
Exhibit 99.2
Joint Filing Agreement
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Catalyst Biosciences, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: July 23, 2019
CCUR HOLDINGS, INC. | |||
By: | /s/ Wayne Barr, Jr | ||
Name: | Wayne Barr, Jr. | ||
Title: | CEO, President and Executive Chairman |
JDS1, LLC | |||
By: | /s/ Julian Singer | ||
Name: | Julian Singer | ||
Title: | Managing Member |
/s/ Wayne Barr,Jr. | |
Wayne Barr,JR. |
/s/ DavidS.Oros | |
David S. Oros |
/s/ Julian Singer | |
Julian Singer |